Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 28;15(1):162-187.
doi: 10.3390/neurolint15010013.

Thwarting Alzheimer's Disease through Healthy Lifestyle Habits: Hope for the Future

Affiliations
Review

Thwarting Alzheimer's Disease through Healthy Lifestyle Habits: Hope for the Future

Vijaya Laxmi Govindugari et al. Neurol Int. .

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that slowly disintegrates memory and thinking skills. Age is known to be the major risk factor in AD, but there are several nonmodifiable and modifiable causes. The nonmodifiable risk factors such as family history, high cholesterol, head injuries, gender, pollution, and genetic aberrations are reported to expediate disease progression. The modifiable risk factors of AD that may help prevent or delay the onset of AD in liable people, which this review focuses on, includes lifestyle, diet, substance use, lack of physical and mental activity, social life, sleep, among other causes. We also discuss how mitigating underlying conditions such as hearing loss and cardiovascular complications could be beneficial in preventing cognitive decline. As the current medications can only treat the manifestations of AD and not the underlying process, healthy lifestyle choices associated with modifiable factors is the best alternative strategy to combat the disease.

Keywords: Alzheimer’s disease; alcohol; cognitive decline; diet; exercise; hearing loss; sleep; smoking; substance abuse.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. James B.D., Leurgans S.E., Hebert L.E., Scherr P.A., Yaffe K., Bennett D.A. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014;82:1045–1050. doi: 10.1212/WNL.0000000000000240. - DOI - PMC - PubMed
    1. Jack C.R., Jr., Bennett D.A., Blennow K., Carrillo M.C., Dunn B., Haeberlein S.B., Holtzman D.M., Jagust W., Jessen F., Karlawish J., et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement. 2018;14:535–562. doi: 10.1016/j.jalz.2018.02.018. - DOI - PMC - PubMed
    1. Karran E., De Strooper B. The amyloid hypothesis in Alzheimer disease: New insights from new therapeutics. Nat. Rev. Drug Discov. 2022;21:306–318. doi: 10.1038/s41573-022-00391-w. - DOI - PubMed
    1. Bang J., Spina S., Miller B.L. Frontotemporal dementia. Lancet. 2015;386:1672–1682. doi: 10.1016/S0140-6736(15)00461-4. - DOI - PMC - PubMed
    1. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839–840. doi: 10.1038/42166. - DOI - PubMed